The beat-and-raise confirms UNH's operational recovery is accelerating. With MCR improving, margins expanding, and guidance raised meaningfully, the stock should re-rate higher. Watch for continued membership trends in Medicare Advantage and Medicaid, and execution on the transparent PBM model. The raised cash flow guidance (~$24B) supports the buyback trajectory.
Price Chart
Executive Summary
UnitedHealth Group reported Q2 2026 GAAP EPS of $6.04 (vs consensus $4.87, +24.0% beat) and revenue of $112.0B (vs consensus $110.82B, +1.1% beat). The company raised full-year 2026 adjusted EPS guidance to $19.50-$20.00 from prior >$17.75, driven by strong medical cost management (MCR 86.7% vs 89.4% a year ago) and improved operating margins across both UnitedHealthcare and Optum. The beat-and-raise signals accelerating operational recovery from 2025 headwinds.
Key Financial Metrics
Key Facts
- Q2 2026 GAAP EPS $6.04 vs consensus $4.87 (beat by +24.0%)
- Q2 2026 revenue $112.0B vs consensus $110.82B (beat by +1.1%)
- Full-year 2026 adjusted EPS guidance raised to $19.50-$20.00 from >$17.75
- Medical cost ratio improved to 86.7% from 89.4% YoY, reflecting pricing discipline and cost management
- Operating cash flow $11.1B (1.9x net income), debt-to-capital ratio improved to 41.2%
- UnitedHealthcare operating margin expanded to 4.6% from 2.4% YoY
- Optum operating margin expanded to 6.2% from 4.6% YoY (160 bps)
- Share repurchases of $4.0B through mid-July; on track for at least $5.0B in 2026
Financial Impact
EPS beat of $1.17 (+24.0%) vs consensus; revenue beat of $1.18B (+1.1%); guidance raised by ~$1.75 at midpoint
Risk Factors
- Medicare Advantage membership declined 965K since year-end 2025; continued attrition could pressure future revenue
- Operating cost ratio increased to 12.7% from 12.3% YoY due to technology investments
- Optum Health revenue declined 5% YoY on 700K fewer value-based care patients
- DOJ legal actions concerning Medicare program participation remain an overhang
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000731766-26-000191 |
| Document: uhgearnings_q22026vpower.htm | 0000731766-26-000191 |
| Document: unh-20260716.htm | 0000731766-26-000191 |
| Document: 0000731766-26-000191-index-headers.html | 0000731766-26-000191 |
| Document: 0000731766-26-000191-index.html | 0000731766-26-000191 |
| Document: 0000731766-26-000191.txt | 0000731766-26-000191 |
| 8-K Data (Synthetic) | 0000731766-26-000191 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 21d ago | Court Ruling | $379.09 $376.90 | ▼ −0.58% | ▼ −0.36% | $365.40 (−3.61%) |
Sep 8, 2026 23d ago | 8-K | $393.06 $378.71 | ▼ −3.65% | ▼ −3.32% | $365.40 (−7.04%) |
Sep 1, 2026 4w ago | Court Ruling | $396.30 $393.06 | ▼ −0.82% | ▼ −0.90% | $365.40 (−7.80%) |
Jul 31, 2026 9w ago | GOVT-CONTRACT | $414.40 $407.08 | ▼ −1.77% | ▼ −5.28% | $365.40 (−11.82%) |
Jul 31, 2026 9w ago | GOVT-CONTRACT | $414.40 $407.08 | ▼ −1.77% | ▼ −5.28% | $365.40 (−11.82%) |
Jul 31, 2026 9w ago | GOVT-CONTRACT | $414.40 $407.08 | ▼ −1.77% | ▼ −5.28% | $365.40 (−11.82%) |
Jul 31, 2026 9w ago | GOVT-CONTRACT | $414.40 $407.08 | ▼ −1.77% | ▼ −5.28% | $365.40 (−11.82%) |
Jul 31, 2026 9w ago | GOVT-CONTRACT | $414.40 $407.08 | ▼ −1.77% | ▼ −5.28% | $365.40 (−11.82%) |
Jul 31, 2026 9w ago | GOVT-CONTRACT | $414.40 $407.08 | ▼ −1.77% | ▼ −5.28% | $365.40 (−11.82%) |
Jul 31, 2026 9w ago | GOVT-CONTRACT | $414.40 $407.08 | ▼ −1.77% | ▼ −5.28% | $365.40 (−11.82%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access